Methyl 1,2,3,4-tetrahydroisoquinoline-5-carboxylate hydrochloride, 95.0%, 250mg

Methyl morpholine-2-carboxylate hydrochloride, 95.0%, 1g

UREA-13C,-15N2, 95.0%, 100mg

4,4'-(Propane-1,3-diylbis(oxy))bis(benzene-1,3-diamine), 95.0%, 5g

2-Aminothiazole, 99.00%, 100g

4,4'-((1,2,3,3,4,4-Hexafluorocyclobutane-1,2-diyl)bis(oxy))bisphenol, 1g

4-Fluoro-2,3-dihydro-1H-inden-1-amine, 97%, 1g

2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide, 95.0%, 25mg

IPRIFLAVONE, 95%, 1g

(4-(1-Cyanocyclopropyl)phenyl)boronic acid, 95.0%, 10g

2-(2-((6-Chlorohexyl)oxy)ethoxy)acetic acid, 95%, 250mg

Recipiente di reazione a flangia piatta, cilindrico, graduato, con camicia di rinvenimento e sottovuoto e valvola di scarico, DN 150, 500 ml, 120 mm, 1 Pezzo

5-Bromobenzo[d]isothiazol-3-amine, 95.0%, 5g